Xenon Pharmaceuticals to Present at Jefferies Inaugural Biotech CNS/Neuro Summit
06 October 2023 - 11:30PM
Xenon Pharmaceuticals Inc. (Nasdaq:XENE), a neurology-focused
biopharmaceutical company, today announced that the company will
present at Jefferies Inaugural Biotech CNS/Neuro Summit to be held
on October 11, 2023.
Company Fireside Chat Presentation Details:
Date: |
Wednesday, October 11, 2023 |
|
|
Time: |
2:25 PM Eastern Time |
|
|
Webcast: |
Register here |
|
|
Presenters: |
Ian Mortimer, President and Chief
Executive OfficerSherry Aulin, Chief Financial Officer |
|
|
A live webcast of the company presentation will be available on
the “Investors” section of Xenon's website and posted for replay
following the event. The above listed dates and times are subject
to change.
About Xenon Pharmaceuticals Inc.
Xenon Pharmaceuticals (NASDAQ:XENE) is a
clinical stage biopharmaceutical company committed to developing
innovative therapeutics to improve the lives of patients with
neurological disorders. We are advancing a novel product pipeline
of neurology therapies to address areas of high unmet medical need,
with a focus on epilepsy. For more information, please visit
www.xenon-pharma.com.
“Xenon” and the Xenon logo are registered
trademarks or trademarks of Xenon Pharmaceuticals Inc. in various
jurisdictions. All other trademarks belong to their respective
owner.
Investor/Media Contact:Jodi RegtsXenon
Pharmaceuticals Inc.Phone: (604) 484-3353Email:
investors@xenon-pharma.com
Xenon Pharmaceuticals (NASDAQ:XENE)
Historical Stock Chart
From May 2024 to Jun 2024
Xenon Pharmaceuticals (NASDAQ:XENE)
Historical Stock Chart
From Jun 2023 to Jun 2024